Dec 11 (Reuters) - Phathom Pharmaceuticals PHAT.O:
PHATHOM PHARMACEUTICALS SUBMITS CITIZEN PETITION TO FDA SEEKING CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA® (VONOPRAZAN) TABLETS
PHATHOM: PETITION REQUESTS CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA 10 MG,20 MG TABLETS TO ACCURATELY REFLECT 10-YEAR NCE EXCLUSIVITY PERIOD
PHATHOM PHARMACEUTICALS INC: EXCLUSIVITY PERIOD IS UNTIL MAY 3, 2032
Source text: ID:nGNXMt0NF
Further company coverage: PHAT.O
((Reuters.Briefs@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。